Literature DB >> 1912440

Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).

L P Fielding1, P A Arsenault, P H Chapuis, O Dent, B Gathright, J D Hardcastle, P Hermanek, J R Jass, R C Newland.   

Abstract

The purpose of tumour staging for colorectal cancer (CRC) is to help define clinical management, facilitate communication between physicians, provide a basis for stratification and analysis of treatment results in prospective studies, and provide some prognostic information for patients and their families. The World Congresses of Gastroenterology, Digestive Endoscopy, and Coloproctology, Working Party on staging for CRC studied six commonly used systems to review their strengths and weaknesses. Although it was concluded that defining a new staging system was unnecessary, it was recognized that there is a need to define a terminology to describe the full anatomic extent of spread of CRC. Furthermore, we note that there are several additional features, derived from both clinical and pathology information, which have had prognostic significance shown by appropriately constructed multivariate analyses and which can be used to formulate a more accurate prognostic index than that provided by a description of anatomical tumour spread. Thus the Working Party came to two principal conclusions. First, a standard format should be adopted for the collection of the essential data required for prospective studies, and we recommend the 'International Documentation System (IDS) for CRC' for this purpose. Second, a nomenclature which describes the full anatomical extent of tumour spread and residual tumour status in CRC has been defined and should be adopted, from which all currently used staging systems can be derived. We have called this nomenclature the 'International Comprehensive Anatomical Terminology (ICAT) for CRC'. In the event that these recommendations are adopted, we envision that there will be improved clarity in the documentation of treatment outcome for patients with CRC and improved communication of results derived from prospective studies. Furthermore, an acceptance of IDS and ICAT would set the scene to develop a prognostic index for individual patients with CRC by the expansion of anatomical clinicopathology staging information to include additional factors which have independent prognostic significance.

Entities:  

Mesh:

Year:  1991        PMID: 1912440     DOI: 10.1111/j.1440-1746.1991.tb00867.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  96 in total

1.  Lymph node harvest in colon and rectal cancer: Current considerations.

Authors:  James R McDonald; Andrew G Renehan; Sarah T O'Dwyer; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2012-01-27

2.  Colorectal Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

3.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Authors:  Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

4.  Better survival of right-sided than left-sided stage II colon cancer: a propensity scores matching analysis based on SEER database.

Authors:  Shuanhu Wang; Xinxin Xu; Jiajia Guan; Rui Huo; Mulin Liu; Congqiao Jiang; Wenbin Wang
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

5.  Nodal spread and micrometastasis within mesorectum.

Authors:  Cun Wang; Zong-Guang Zhou; Zhao Wang; Dai-Yun Chen; Yang-Chun Zheng; Gao-Ping Zhao
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 6.  [Problems with residual tumor classification, particularly R1].

Authors:  C Wittekind
Journal:  Chirurg       Date:  2007-09       Impact factor: 0.955

7.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

8.  Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.

Authors:  N P Zauber; C Wang; P S Lee; T C Redondo; D T Bishop; A Goel
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

9.  Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes.

Authors:  Hsiang-Lin Tsai; Yung-Sung Yeh; Fang-Jung Yu; Chien-Yu Lu; Chin-Fan Chen; Chao-Wen Chen; Yu-Tang Chang; Jaw-Yuan Wang
Journal:  Int J Colorectal Dis       Date:  2008-10-14       Impact factor: 2.571

Review 10.  Non-surgical factors influencing lymph node yield in colon cancer.

Authors:  Patrick Wood; Colin Peirce; Jurgen Mulsow
Journal:  World J Gastrointest Oncol       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.